Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2008-06-30
2011-11-15
Berch, Mark (Department: 1622)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
active
08058430
ABSTRACT:
The subject invention provides novel compositions of biologically active compounds which can advantageously be used in blocking cellular proliferation and/or treatment of cancer. Exemplified are:
REFERENCES:
patent: 5252569 (1993-10-01), Hajos et al.
patent: 5543423 (1996-08-01), Zelle et al.
patent: 5723459 (1998-03-01), Armistead et al.
patent: 7094803 (2006-08-01), Killday et al.
patent: 7179828 (2007-02-01), Wright et al.
patent: 2005/0009901 (2005-01-01), Wright et al.
patent: 2006/0264499 (2006-11-01), Wright et al.
Barrand, M.A. et al., “Multidrug Resistance-Associated Protein: A Protein Distinct from P-glycoprotein Involved in Cytotoxic Drug Expulsion,”General Pharmacology, 1997, vol. 28, No. 5, pp. 639-645.
Bellamy, W.T., “P-Glycoproteins and Multidrug Resistance,”Annu. Rev. Pharmacol. Toxicol., 1996, vol. 36, pp. 161-183.
Broxterman, H.J. et al., “Multidrug Resistance Proteins and Other Drug Transport-Related Resistance to Natural Product Agents,”Current Opinion in Oncology, 1995, vol. 7, pp. 532-540, Abstract only.
Komarov, P.G. et al. “Activation of the LRP (lung resistance-related protein) gene by short-term exposure of human leukemia cells to phorbol ester and cytarabine,”Oncology Research, 1998, vol. 10, pp. 185-192, Abstract only.
Krishan, A. et al., “Drug Retention, Efflux, and Resistance in Tumor Cells,”Cytometry, 1997, vol. 29, pp. 279-285.
Miller, D. W. et al., “The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell lines,”Cancer Letters, 1996, vol. 107, pages 301-306.
Guzman Esther A.
McCarthy Peter J.
Pomponi Shirley A.
Sennett Susan H.
Wright Amy E.
Berch Mark
Florida Atlantic University Broad of Trustees
Saliwanchik Lloyd & Eisenschenk
LandOfFree
Biologically active aphrocallistin compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biologically active aphrocallistin compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biologically active aphrocallistin compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4291421